Walleye Trading
CRL icon

Walleye Trading’s Charles River Laboratories CRL Stock Holding History

Walleye Trading’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$569K Sell
2,511
-29,150
-92% -$5.19M ﹤0.01% 2615
2026
Q1 		$5.46M Buy
31,661
+30,726
+3,286% +$5.7M 0.01% 1099
2025
Q4 		$187K Buy
+935
New +$170K ﹤0.01% 3425
2025
Q3 		– Sell
-2,177
Closed -$346K – 4452
2025
Q2 		$330K Buy
2,177
+189
+10% +$25.2K ﹤0.01% 2932
2025
Q1 		$299K Buy
1,988
+653
+49% +$109K ﹤0.01% 2835
2024
Q4 		$246K Sell
1,335
-5,619
-81% -$1.08M ﹤0.01% 3117
2024
Q3 		$1.37M Buy
+6,954
New +$1.45M ﹤0.01% 1921
2023
Q4 		– Sell
-11,112
Closed -$2.19M – 5127
2023
Q3 		$2.18M Buy
+11,112
New +$2.28M 0.01% 1724
2022
Q2 		– Sell
-1,231
Closed -$301K – 5206
2022
Q1 		$350K Sell
1,231
-1,375
-53% -$424K ﹤0.01% 3304
2021
Q4 		$982K Sell
2,606
-486
-16% -$189K ﹤0.01% 2248
2021
Q3 		$1.28M Buy
3,092
+691
+29% +$287K ﹤0.01% 1972
2021
Q2 		$888K Buy
+2,401
New +$802K ﹤0.01% 2264
2020
Q3 		– Sell
-459
Closed -$95.3K – 4181
2020
Q2 		$80K Buy
+459
New +$73.3K ﹤0.01% 3621
2019
Q4 		– Sell
-3,285
Closed -$455K – 4287
2019
Q3 		$435K Buy
+3,285
New +$440K ﹤0.01% 2277
2017
Q3 		– Sell
-94
Closed -$10 – 4169
2017
Q2 		$10 Buy
+94
New +$8.65K ﹤0.01% 4245
2017
Q1 		– Sell
-600
Closed -$46K – 4735
2016
Q4 		$46K Buy
600
+411
+217% +$31.2K ﹤0.01% 3686
2016
Q3 		$16K Buy
+189
New +$15.8K ﹤0.01% 4257
2016
Q2 		– Sell
-1,600
Closed -$122K – 5367
2016
Q1 		$122K Buy
1,600
+731
+84% +$54.1K ﹤0.01% 3180
2015
Q4 		$70K Buy
+869
New +$62.7K ﹤0.01% 3585
2014
Q4 		– Sell
-203
Closed -$12K – 4269
2014
Q3 		$12K Buy
+203
New +$11.6K ﹤0.01% 3726

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Walleye Trading's CRL Position: Q2 2026 in Review

Walleye Trading reduced its Charles River Laboratories (CRL) stake by 92% in Q2 2026, selling an estimated $5.19M and leaving 2,511 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Walleye Trading first reported a position in CRL in Q3 2014 and has held it in 20 quarters since. The position peaked at $5.46M in Q1 2026. 260 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Walleye Trading held 2,511 shares of Charles River Laboratories worth $569K as of Q2 2026.
  • Walleye Trading sold 29,150 Charles River Laboratories shares in Q2 2026, an estimated $5.19M.
  • Charles River Laboratories made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2615 holding.
  • Walleye Trading first reported a position in Charles River Laboratories in Q3 2014 and has held it in 20 quarters since.
  • Walleye Trading's Charles River Laboratories position peaked at $5.46M in Q1 2026.
  • 260 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.